ℹ️
🇬🇧
Search
Search for people relevant for "PBI"
PBI
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Petr Arenberger DrSc., MBA
Academic staff at Third Faculty of Medicine
16 classes
227 publications
Classes
class
Student Research Activity
C4SVA110 |
Third Faculty of Medicine
class
Dermatovenerology
+3
C5VL004 |
Third Faculty of Medicine
class
Atopic dermatitis
+1
CCOC6909 |
Third Faculty of Medicine
class
Dermatology and Diseases of the Mucosa
+2
CDH003P2 |
Third Faculty of Medicine
class
ERASMUS - Dermatovenerology
CERA5P0076 |
Third Faculty of Medicine
class
IIC - 10. Cutaneous Changes
CMCP1034 |
Third Faculty of Medicine
class
IIB - Dermatovenerology
CMPRKL23 |
Third Faculty of Medicine
class
Nursing Care in Dermatovenerology
+2
CNS012P2 |
Third Faculty of Medicine
Load more classes (6)
Publications
publication
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic
2024 |
Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
BIOREP - Biologic/Targeted Therapy Registry: 2022 Summary Report
2023 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Employing Adalimumab in Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Real-Life Multicenter Data from the Czech Republic
2023 |
Third Faculty of Medicine, First Faculty of Medicine
publication
Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 238
2023 |
Third Faculty of Medicine
publication
Malignant melanoma: diagnosis and treatment based on current guidelines
2023 |
Third Faculty of Medicine
publication
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies
2023 |
Third Faculty of Medicine
publication
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
2023 |
Central Library of Charles University
publication
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023
2023 |
Third Faculty of Medicine
publication
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023
2023 |
Third Faculty of Medicine
publication
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023
2023 |
Third Faculty of Medicine
Load more publications (217)
Loading network view...